vs

Side-by-side financial comparison of Inogen Inc (INGN) and LandBridge Co LLC (LB). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $56.8M, roughly 1.2× LandBridge Co LLC). On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs 3.4%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-1.9M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 4.2%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

INGN vs LB — Head-to-Head

Bigger by revenue
INGN
INGN
1.2× larger
INGN
$68.6M
$56.8M
LB
Growing faster (revenue YoY)
LB
LB
+52.1% gap
LB
55.6%
3.4%
INGN
More free cash flow
LB
LB
$124.0M more FCF
LB
$122.0M
$-1.9M
INGN
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
LB
LB
Revenue
$68.6M
$56.8M
Net Profit
$8.1M
Gross Margin
51.4%
Operating Margin
-13.6%
60.0%
Net Margin
14.2%
Revenue YoY
3.4%
55.6%
Net Profit YoY
-83.7%
EPS (diluted)
$-0.26
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
LB
LB
Q4 25
$68.6M
$56.8M
Q3 25
$79.1M
$50.8M
Q2 25
$79.2M
$47.5M
Q1 25
$68.5M
$44.0M
Q4 24
$66.3M
$36.5M
Q3 24
$74.9M
$28.5M
Q2 24
$74.4M
$26.0M
Q1 24
$63.1M
$19.0M
Net Profit
INGN
INGN
LB
LB
Q4 25
$8.1M
Q3 25
$-5.3M
$8.1M
Q2 25
$-4.2M
$7.5M
Q1 25
$-6.2M
$6.5M
Q4 24
$49.3M
Q3 24
$-6.0M
$2.7M
Q2 24
$-5.6M
$-57.7M
Q1 24
$-14.6M
$10.8M
Gross Margin
INGN
INGN
LB
LB
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
INGN
INGN
LB
LB
Q4 25
-13.6%
60.0%
Q3 25
-9.0%
60.8%
Q2 25
-7.7%
60.0%
Q1 25
-11.2%
57.0%
Q4 24
-17.2%
49.4%
Q3 24
-10.4%
11.2%
Q2 24
-9.5%
-197.4%
Q1 24
-25.8%
71.1%
Net Margin
INGN
INGN
LB
LB
Q4 25
14.2%
Q3 25
-6.7%
15.9%
Q2 25
-5.2%
15.8%
Q1 25
-9.0%
14.7%
Q4 24
135.2%
Q3 24
-8.0%
9.3%
Q2 24
-7.5%
-222.1%
Q1 24
-23.1%
56.7%
EPS (diluted)
INGN
INGN
LB
LB
Q4 25
$-0.26
$0.24
Q3 25
$-0.20
$0.26
Q2 25
$-0.15
$0.24
Q1 25
$-0.25
$0.20
Q4 24
$-0.41
Q3 24
$-0.25
$-0.04
Q2 24
$-0.24
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
LB
LB
Cash + ST InvestmentsLiquidity on hand
$103.7M
$30.7M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$192.2M
$340.3M
Total Assets
$298.6M
$1.4B
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
LB
LB
Q4 25
$103.7M
$30.7M
Q3 25
$106.5M
$28.3M
Q2 25
$103.7M
$20.3M
Q1 25
$118.9M
$14.9M
Q4 24
$113.8M
$37.0M
Q3 24
$105.7M
$14.4M
Q2 24
$97.9M
$24.6M
Q1 24
$107.4M
Total Debt
INGN
INGN
LB
LB
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
INGN
INGN
LB
LB
Q4 25
$192.2M
$340.3M
Q3 25
$197.2M
$272.0M
Q2 25
$199.5M
$266.4M
Q1 25
$198.0M
$217.0M
Q4 24
$173.9M
$211.8M
Q3 24
$185.4M
$97.2M
Q2 24
$187.6M
$296.4M
Q1 24
$191.9M
$162.3M
Total Assets
INGN
INGN
LB
LB
Q4 25
$298.6M
$1.4B
Q3 25
$307.0M
$1.1B
Q2 25
$312.0M
$1.1B
Q1 25
$308.4M
$1.0B
Q4 24
$296.2M
$1.0B
Q3 24
$306.2M
$689.9M
Q2 24
$308.9M
$710.5M
Q1 24
$315.6M
Debt / Equity
INGN
INGN
LB
LB
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
LB
LB
Operating Cash FlowLast quarter
$-943.0K
$126.3M
Free Cash FlowOCF − Capex
$-1.9M
$122.0M
FCF MarginFCF / Revenue
-2.8%
214.9%
Capex IntensityCapex / Revenue
1.4%
7.5%
Cash ConversionOCF / Net Profit
15.68×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$207.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
LB
LB
Q4 25
$-943.0K
$126.3M
Q3 25
$2.2M
$34.9M
Q2 25
$4.3M
$37.3M
Q1 25
$-16.8M
$15.9M
Q4 24
$-3.0M
$67.6M
Q3 24
$7.0M
$7.5M
Q2 24
$6.7M
$16.0M
Q1 24
$-4.7M
$17.2M
Free Cash Flow
INGN
INGN
LB
LB
Q4 25
$-1.9M
$122.0M
Q3 25
$1.6M
$33.7M
Q2 25
$3.7M
$36.1M
Q1 25
$-17.1M
$15.8M
Q4 24
$-3.3M
$66.7M
Q3 24
$5.3M
$7.1M
Q2 24
$6.6M
$15.7M
Q1 24
$-6.1M
$17.1M
FCF Margin
INGN
INGN
LB
LB
Q4 25
-2.8%
214.9%
Q3 25
2.0%
66.3%
Q2 25
4.6%
75.9%
Q1 25
-24.9%
36.0%
Q4 24
-5.0%
182.6%
Q3 24
7.1%
25.1%
Q2 24
8.9%
60.4%
Q1 24
-9.6%
90.1%
Capex Intensity
INGN
INGN
LB
LB
Q4 25
1.4%
7.5%
Q3 25
0.7%
2.3%
Q2 25
0.9%
2.6%
Q1 25
0.4%
0.2%
Q4 24
0.5%
2.7%
Q3 24
2.2%
1.1%
Q2 24
0.1%
1.4%
Q1 24
2.1%
0.5%
Cash Conversion
INGN
INGN
LB
LB
Q4 25
15.68×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
2.80×
Q2 24
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

LB
LB

Segment breakdown not available.

Related Comparisons